Literature DB >> 11904147

Caspase 3 regulates phosphatidylserine externalization and phagocytosis of oxidatively stressed erythrocytes.

Debabrata Mandal1, Prasun K Moitra, Samiran Saha, Joyoti Basu.   

Abstract

The appearance of phosphatidylserine (PS) on the outer surface of red cells is an important signal for their uptake by macrophages. We report for the first time that procaspase 3 present in the anucleated mature human erythrocyte is activated under oxidative stress induced by t-butylhydroperoxide leading to impairment of the aminophospholipid translocase, PS externalization and increased erythrophagocytosis. This is the first report linking caspase 3 activation to inhibition of flippase activity and uptake of red cells by macrophages.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11904147     DOI: 10.1016/s0014-5793(02)02294-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  42 in total

Review 1.  Aging and death signalling in mature red cells: from basic science to transfusion practice.

Authors:  Marianna H Antonelou; Anastasios G Kriebardis; Issidora S Papassideri
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

Review 2.  Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.

Authors:  D Allan Butterfield; Miranda L Bader Lange; Rukhsana Sultana
Journal:  Biochim Biophys Acta       Date:  2010-02-20

3.  Derangement of erythrocytic AE1 in beta-thalassemia by caspase 3: pathogenic mechanisms and implications in red blood cell senescence.

Authors:  Silvana Ficarra; Ester Tellone; Bruno Giardina; Roberto Scatena; Annamaria Russo; Francesco Misiti; M Elisabetta Clementi; Deborah Colucci; Ersilia Bellocco; Giuseppina Laganà; Davide Barreca; Antonio Galtieri
Journal:  J Membr Biol       Date:  2009-02-24       Impact factor: 1.843

4.  Exosomes from red blood cell units bind to monocytes and induce proinflammatory cytokines, boosting T-cell responses in vitro.

Authors:  Ali Danesh; Heather C Inglis; Rachael P Jackman; Shiquan Wu; Xutao Deng; Marcus O Muench; John W Heitman; Philip J Norris
Journal:  Blood       Date:  2013-12-12       Impact factor: 22.113

5.  Oxidative effects of gemfibrozil on anion influx and metabolism in normal and Beta-thalassemic erythrocytes: physiological implications.

Authors:  Ester Tellone; Silvana Ficarra; Bruno Giardina; Roberto Scatena; Annamaria Russo; M Elisabetta Clementi; Francesco Misiti; Ersilia Bellocco; Antonio Galtieri
Journal:  J Membr Biol       Date:  2008-09-29       Impact factor: 1.843

6.  Engineering erythrocytes as a novel carrier for the targeted delivery of the anticancer drug paclitaxel.

Authors:  Gamaleldin I Harisa; Mohamed F Ibrahim; Fars Alanazi; Gamal A Shazly
Journal:  Saudi Pharm J       Date:  2013-01-07       Impact factor: 4.330

7.  An anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase (ERK) pathway and inhibits growth of breast cancer cells.

Authors:  YuMing Guo; XinTian Zhang; Jun Meng; Zhao-Yi Wang
Journal:  Eur J Pharmacol       Date:  2011-03-01       Impact factor: 4.432

Review 8.  Disassembly of dying cells in diverse organisms.

Authors:  Rochelle Tixeira; Ivan K H Poon
Journal:  Cell Mol Life Sci       Date:  2018-10-13       Impact factor: 9.261

9.  Age-related loss of phospholipid asymmetry in APP(NLh)/APP(NLh) x PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice: relevance to Alzheimer disease.

Authors:  Miranda L Bader Lange; Daret St Clair; William R Markesbery; Christa M Studzinski; M Paul Murphy; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2010-01-18       Impact factor: 5.996

10.  Hemolysis is associated with low reticulocyte production index and predicts blood transfusion in severe malarial anemia.

Authors:  Rolf Fendel; Christian Brandts; Annika Rudat; Andrea Kreidenweiss; Claudia Steur; Iris Appelmann; Bettina Ruehe; Paul Schröder; Wolfgang E Berdel; Peter G Kremsner; Benjamin Mordmüller
Journal:  PLoS One       Date:  2010-04-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.